IIM
NVCR icon

INTECH Investment Management’s NovoCure NVCR Stock Holding History

INTECH Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Sell
32,580
-6,414
-16% -$97.1K ﹤0.01% 1353
2026
Q1 		$425K Sell
38,994
-29,317
-43% -$366K ﹤0.01% 1412
2025
Q4 		$883K Buy
68,311
+15,030
+28% +$193K 0.01% 1197
2025
Q3 		$688K Buy
53,281
+6,658
+14% +$89K 0.01% 1394
2025
Q2 		$830K Sell
46,623
-7,511
-14% -$131K 0.01% 1314
2025
Q1 		$965K Buy
54,134
+28,354
+110% +$644K 0.01% 1218
2024
Q4 		$768K Buy
25,780
+3,637
+16% +$77K 0.01% 1308
2024
Q3 		$346K Buy
+22,143
New +$402K ﹤0.01% 1434
2023
Q4 		– Sell
-12,614
Closed -$204K – 732
2023
Q3 		$204K Sell
12,614
-5,731
-31% -$165K ﹤0.01% 696
2023
Q2 		$761K Sell
18,345
-13,663
-43% -$848K 0.01% 520
2023
Q1 		$1.92M Buy
32,008
+5,229
+20% +$418K 0.02% 457
2022
Q4 		$1.96M Buy
26,779
+24,072
+889% +$1.81M 0.01% 449
2022
Q3 		$206K Sell
2,707
-2,338
-46% -$182K ﹤0.01% 648
2022
Q2 		$351K Buy
+5,045
New +$380K ﹤0.01% 639

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

INTECH Investment Management's NVCR Position: Q2 2026 in Review

INTECH Investment Management reduced its NovoCure (NVCR) stake by 16% in Q2 2026, selling an estimated $97.1K and leaving 32,580 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

INTECH Investment Management first reported a position in NVCR in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.96M in Q4 2022. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • INTECH Investment Management held 32,580 shares of NovoCure worth $494K as of Q2 2026.
  • INTECH Investment Management sold 6,414 NovoCure shares in Q2 2026, an estimated $97.1K.
  • NovoCure made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1353 holding.
  • INTECH Investment Management first reported a position in NovoCure in Q2 2022 and has held it in 14 quarters since.
  • INTECH Investment Management's NovoCure position peaked at $1.96M in Q4 2022.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.